The latest announcement is out from Argent Biopharma ( (AU:RGT) ).
Argent Biopharma Limited has announced the appointment of Gary Hermon as a director, effective March 5, 2025. The announcement indicates that Hermon currently holds no relevant interests in securities or contracts related to the company. This appointment could potentially influence the company’s strategic direction and governance, impacting its market positioning and stakeholder relations.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is dedicated to addressing unmet medical needs and improving patient outcomes through advanced biopharmaceutical solutions.
YTD Price Performance: -52.50%
Average Trading Volume: 135,660
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.61M
Learn more about RGT stock on TipRanks’ Stock Analysis page.